Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women

Metabolism: Clinical and Experimental

Volumn 56, Issue 7, 2007, Pages 910-914

  Welty, Francine K ^b   Lichtenstein, Alice H ^a   Lamon Fava, Stefania ^a   Schaefer, Ernst J ^a   Marsh, Julian B ^a  

^a TUFTS UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEIN A-I; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; OBESITY; POSTMENOPAUSE;

EID: 34250003177     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.01.022     Document Type: Article

References (21)

1. Gordon D.J., and Rifkind B.M. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med 321 (1989) 1311-1316
2. Li Z., McNamara J.R., Fruchart J.-C., et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res 37 (1996) 1886-1896
3. Ooi E.M.M., Watts G.F., Farvid M.S., et al. High-density lipoprotein apolipoprotein A-I kinetics in obesity. Obesity Res 13 (2005) 1008-1018
4. Tilly-Kiesi M., Lichtenstein A.H., Joven J., et al. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects. Arterioscler Thromb Vasc Biol 17 (1997) 3513-3518
5. 3-leucine in middle aged and elderly men and women. Arterioscler Thromb Vasc Biol 20 (2000) 801-806
6. Cohn J.S., McNamara J.R., Cohn S.D., Ordovas J.M., and Schaefer E.J. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res 29 (1988) 925-936
7. Welty F.K., Lichtenstein A.H., Barrett P.H.R., Dolnikowski G.G., and Schaefer E.J. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Arterioscler Thromb Vasc Biol 24 (2004) 1703-1707
8. Welty F.K., Lichtenstein A.H., Barrett P.H.R., Dolnikowski G.G., and Schaefer E.J. Human apolipoprotein (apo) B-48 and apoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol 19 (1999) 2966-2974
9. Contois J., McNamara J.R., Lammi-Keefe C., et al. Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 42 (1996) 507-514
10. Batista M.C., Welty F.K., Diffenderfer M.R., et al. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism 53 (2004) 1254-1260
11. Dagher F.J., Lyons J.H., Finlayson D.C., Shamsai T., and Moore F.D. Blood volume measurement-a critical study. Advances in Surgery 1 (1965) 69-109
12. Morrison J.A., Sprecher D.L., Biro F.M., Apperson-Hansen C., and DiPaola L.M. Serum testosterone associates with lower high-density lipoprotein cholesterol in black and white males, 10 to 15 years of age, through lowered apolipoprotein AI and AII concentrations. Metabolism 51 (2002) 432-437
13. Schaefer E.J., Foster D.M., Zech L.A., et al. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal women. J Clin Endocrinol Metab 57 (1983) 262-267
14. Lamon-Fava S., Postfai B., Diffenderfer M., et al. Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Arterioscler Thromb Vasc Biol 26 (2006) 385-391
15. Terry R.B., Yurgalevitch S., and Thompson P.D. High-density apolipoprotein A-I and A-II kinetics in relation to regional adiposity. Metabolism 41 (1992) 1386-1392
16. Brinton E.A., Eisenberg S., and Breslow J.L. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb 14 (1994) 707-720
17. Vajo Z., Terry J.G., and Brinton E.A. Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women. Atherosclerosis 160 (2002) 495-501
18. Lecerf J.M., Masson A., Fruchart J.C., and Bard J.M. Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjects. Diabetes Metab 22 (1996) 331-340
19. Larsson B., Bengtsson C., Bjorntorp P., et al. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol 135 (1992) 266-273
20. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95 (1997) 252-264
21. Verges B., Petit J.M., Duvillard L., et al. Adiponectin is an important determinant of apo A-I catabolism. Arterioscler Thromb Vasc Biol 26 (2006) 1364-1369